RX 77368

Drug Profile

RX 77368

Alternative Names: Thymoliberin

Latest Information Update: 18 Sep 1997

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Reckitt Benckiser
  • Developer Ferring Pharmaceuticals; Reckitt Benckiser
  • Class Antidepressants; Cytoprotectives
  • Mechanism of Action Thyrotropin releasing hormone stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Learning disorders; Major depressive disorder; Motor neuron disease; Peptic ulcer

Most Recent Events

  • 18 Sep 1997 Discontinued-Clinical for Peptic ulcer in United Kingdom (unspecified route)
  • 18 Sep 1997 Discontinued-II for Motor neuron disorders in Sweden (unspecified route)
  • 18 Sep 1997 Discontinued-Preclinical for Learning disorders in United Kingdom (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top